Purpose of the Study

People whose immune systems are affected by a medical condition or treatment may be at a higher risk of complications from influenza. Researchers are studying an investigational approach to flu prevention in this population. Eligibility may depend on your diagnosis, the type and timing of treatment, current medications, and overall medical stability

Study Requirements

You may qualify if you:
Have certain stable lung, heart, kidney, asthma, or insulin-dependent diabetes-related conditions
Have an immunocompromising diagnosis
Recently received certain cancer or immune-related treatments
Take qualifying medicine that affects immune function

Study Locations

This study is currently enrolling at the following sites:

Starling Oncology (Formerly The Oncology Institute) Powered by Helios Clinical Research - Fort Lauderdale, FL
Helios Clinical Research - Cleveland, OH

Potential Benefits of Participation

Maginfying

Access to new treatments that are not yet available to the general public.

Hand Heart

Personalized medical attention from leading healthcare professionals.

Helios

Compensation for study-related time and travel

About Helios Clinical

Helios Clinical is dedicated to advancing medical research through innovative clinical trials.
Our mission is to discover new ways to improve patient health and outcomes.
We collaborate with leading healthcare professionals and scientists
to ensure the highest standards of research and care for our participants.